Sponsored Links
| FDA Approves Colcrys(TM) (colchicine, USP) For Prevention Of Gout Flares |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare. Colcrys is an oral, branded form of colchicine that has been formulated for optimal efficacy and tolerability. Read more: Pharma Industry / Biotech Industry News From Medical News Today
|